• Flanders Investment & Trade
  • Team Vesalius

Dr. Bruno Holthof is the current CEO of Oxford University Hospitals and has been closely involved in Oxford’s research and clinical response to the COVID-19 pandemic.

Bruno Holthof

Oxford University Hospitals

Prior to that, Holthof headed the Antwerp Hospital Network, transforming it into the most profitable hospital group in Belgium. Before becoming a CEO, Holthof was a partner at McKinsey & Company. During that time, he served a wide range of healthcare clients in Europe and the US and gained significant expertise in the areas of strategy, organization and operations

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?